Supplement safety claims are often based on anecdote or a single small trial. Rhodiola rosea is one of the better-documented cases because independent researchers have pooled and critically reviewed multiple placebo-controlled trials specifically looking at adverse events, not just efficacy. This article summarizes what those systematic reviews found.
Key Takeaways
- A systematic review of 11 placebo-controlled randomized trials found generally moderate-to-good methodological quality and few mild adverse events.
- A separate systematic review focused specifically on fatigue trials reached a similar conclusion: research is contradictory on efficacy, but adverse events reported were minimal.
- A 2022 systematic review of exercise/sport studies found no obvious adverse reactions across the reviewed trials.
- “Few reported adverse events in short trials” is not the same as “proven safe for everyone long-term” — the reviews themselves note a need for more rigorous, longer research.
What the Broadest Safety Review Found
A systematic review covering 11 placebo-controlled randomized controlled trials of Rhodiola rosea, six on physical performance, four on mental performance, and two in patients with diagnosed mental health conditions, assessed trial quality as moderate to good in most cases and reported only a few mild adverse events across all of them[1]. The authors’ overall conclusion was that R. rosea may have beneficial effects across these domains, while also flagging a lack of independent replication as a real limitation on how confidently the findings should be generalized.
The Fatigue-Specific Review
A separate systematic review searched six databases specifically for trials on R. rosea for physical and mental fatigue, screening 206 articles down to 11 that met inclusion criteria (10 RCTs, 1 controlled clinical trial)[2]. This review was more skeptical about efficacy, describing the evidence as contradictory due to methodological flaws in several trials, but it did not flag a pattern of significant adverse events either, the safety signal across these fatigue-focused trials was consistently mild.
The Exercise and Sport Review
A 2022 systematic review focused on Rhodiola rosea in exercise and sport contexts evaluated 10 papers and reported that most found a positive effect on athletic performance, with no obvious adverse reactions noted across the reviewed studies[3]. Exercise trials are a useful safety data point because they often involve physiological stress testing that could plausibly reveal cardiovascular or other strain-related side effects, and none of the reviewed studies flagged that pattern.
Reading the Safety Data Honestly
Across three independent systematic reviews spanning fatigue, mental health, and exercise contexts, the consistent theme is mild and infrequent adverse events in short-term trials, not zero risk. These reviews all explicitly call for more rigorous, larger, and longer-duration research, meaning the safety picture for extended use (months to years) is less well-characterized than the picture for the multi-week trial durations typically studied. If you experience jitteriness, insomnia, dizziness, or dry mouth, commonly reported mild effects with adaptogenic herbs, stop and reassess, and talk to a healthcare provider if symptoms persist or if you’re pregnant, breastfeeding, or on other medications. These statements have not been evaluated by the FDA, and rhodiola is not intended to diagnose, treat, cure, or prevent any disease.

Frequently Asked Questions
What are the most common Rhodiola rosea side effects?
Systematic reviews of placebo-controlled trials report only mild and infrequent adverse events overall; commonly noted mild effects with adaptogenic herbs like rhodiola include jitteriness, insomnia, dizziness, or dry mouth in sensitive individuals.
Is Rhodiola rosea proven safe for long-term use?
The systematic reviews cover trials of weeks to a few months, and their authors explicitly call for more rigorous, longer-duration research, so long-term safety data is less established than short-term trial safety.
Did the exercise studies find any safety concerns?
A 2022 systematic review of 10 exercise and sport studies reported no obvious adverse reactions across the reviewed trials.
References
- Hung SK, Perry R, Ernst E. The effectiveness and efficacy of Rhodiola rosea L.: a systematic review of randomized clinical trials. Phytomedicine (2011). PMID 21036578
- Ishaque S, Shamseer L, Bukutu C, Vohra S. Rhodiola rosea for physical and mental fatigue: a systematic review. BMC Complementary and Alternative Medicine (2012). PMID 22643043
- Lu Y et al. Effects of Rhodiola Rosea Supplementation on Exercise and Sport: A Systematic Review. Frontiers in Nutrition (2022). PMID 35464040
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.



